# UK Atherectomy Devices Market > UK Atherectomy Devices Market Research Report: Size, Share, Trend Analysis By Types (Directional Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices), By Applications (Coronary Artery Disease, Peripheral Artery Disease, Carotid Artery Disease), By End-user (Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers), and By Material (Stainless Steel, Polymers, Composites) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.5% - **2024:** $ 65.48 Million - **2025:** $ 68.43 Million - **2035:** $ 106.25 Million - **Key Players:** Boston Scientific (US), Medtronic (US), Abbott Laboratories (US), Cardiovascular Systems (US), Spectranetics (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Philips (NL) **Report ID:** MRFR/HC/63972-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/uk-atherectomy-devices-market-53813 --- ## Market Summary ## **UK Atherectomy Devices Market Overview** As per MRFR analysis, the UK Atherectomy Devices Market Size was estimated at 95.19 (USD Million) in 2023.The UK Atherectomy Devices Market is expected to grow from 99.73(USD Million) in 2024 to 177.19 (USD Million) by 2035. The UK Atherectomy Devices Market CAGR (growth rate) is expected to be around 5.364% during the forecast period (2025 - 2035). **Key UK Atherectomy Devices Market Trends Highlighted** The market for atherectomy devices in the UK is seeing notable developments due to rising awareness of cardiovascular illnesses and technological advancements. The growing incidence of coronary artery disease and atherosclerosis in the UK population is one of the major market drivers. The demand for atherectomy devices, which are well-known for their effectiveness in removing plaque from blood vessels, is driven by the National Health Service's (NHS) recognition of the significance of increasing treatment alternatives. Furthermore, as patients and medical professionals look for less traumatic alternatives to standard surgery, the increasing emphasis on less invasive treatments is changing treatment paradigms. Potential growth for new competitors providing creative and effective atherectomy options is one of the market's opportunities. With a number of medical technology businesses aiming to launch next-generation gadgets that improve safety and efficacy, research and development is picking up speed. Additionally, better training and awareness are being produced by partnerships between hospitals and technology companies, which may boost adoption rates in the UK healthcare industry. The advantages of atherectomy treatments over other revascularization techniques have garnered more attention recently as doctors are becoming aware of the benefits of lowering the risks connected with stenting and bypass surgery. Furthermore, it is anticipated that increasing access to sophisticated atherectomy treatments will be made possible by increased investment in healthcare infrastructure in line with national health policy. The market for atherectomy devices should continue to expand as a result of this trend, which is consistent with the NHS's mission to enhance cardiovascular health and outcomes for patients in the UK. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **UK Atherectomy Devices Market Drivers** **Increasing Prevalence of Cardiovascular Diseases** The rise in cardiovascular diseases in the UK is a crucial driver for the UK [Atherectomy Devices Market](../../../reports/atherectomy-devices-market-7322). Statistics indicate that over 7 million people in the UK are living with cardiovascular diseases, a number that has been consistently rising over the past decade according to the British Heart Foundation. The increasing number of patients requiring procedures such as revascularization creates a significant demand for atherectomy devices. Furthermore, advancements in technology and output from established organizations such as Medtronic and Boston Scientific have led to the development of more efficient atherectomy devices, further driving market growth as healthcare providers seek optimal outcomes for patients with cardiovascular issues. The UK government's recent focus on improving cardiovascular healthcare is also aiding in increasing the adoption of these devices, pushing the market potential upwards. **Technological Advancements in Atherectomy Devices** Technological innovations in the design and functionality of atherectomy devices significantly impact the UK Atherectomy Devices Market. For instance, the introduction of laser-assisted atherectomy devices and rotational atherectomy systems has been pivotal in improving patient outcomes while reducing recovery times. With R&D investments from major players like Philips and Abbott Laboratories, advanced products are emerging that not only enhance procedural efficiency but also improve safety for patients. The UK’s National Institute for Health and Care Excellence has endorsed several of these technologies, further validating their importance and effectiveness, which in turn fosters market growth. **Government Initiatives for Improved Cardiovascular Management** Government initiatives aimed at improving cardiovascular health services greatly influence the UK Atherectomy Devices Market. With policies from the National Health Service stressing the importance of early detection and management of cardiovascular diseases, investment in medical technologies is on the rise. The UK government’s commitment to reducing cardiovascular mortality rates by 2025 encourages the adoption of advanced treatment options like atherectomy devices. This governmental push not only raises awareness among healthcare providers but also leads to increased funding for hospitals to procure advanced devices, thus driving market growth. **Growing Elderly Population** The growing elderly population in the UK is a significant market driver for the UK Atherectomy Devices Market. As it is well-known that older adults are at a heightened risk for cardiovascular diseases, the Office for National Statistics has reported that the proportion of individuals aged 65 and over is forecasted to rise by approximately 23% over the next decade. With rising age comes an increasing demand for surgical procedures to manage cardiovascular conditions, thereby escalating the demand for atherectomy devices. This trend encourages manufacturers and healthcare facilities to invest in newer technologies and devices, supporting market growth in the long term. **UK Atherectomy Devices Market Segment Insights** **Atherectomy Devices Market Type Insights** The UK Atherectomy Devices Market exhibits a diverse composition characterized by several key types of devices pivotal in the treatment of coronary artery disease and peripheral arterial disease. Directional Atherectomy Devices play a vital role in selectively removing arterial plaque while preserving the healthy vessel wall, ensuring a balanced approach to patient recovery. This type of device typically utilizes a cutting mechanism that directs plaque towards an extraction port, thus optimizing outcomes for patients experiencing blockages. On the other hand, Orbital Atherectomy Devices have gained attention for their ability to use a unique orbital mechanism to effectively treat calcified lesions, offering an effective solution for complex cases that other devices might struggle with. The significance of these devices lies in their capacity to enhance procedural efficiency and improve the longevity of vascular interventions. In addition, Laser Atherectomy Devices have revolutionized the way vascular lesions are approached. Using laser energy, these devices can ablate hard and soft plaque, allowing for precise targeting and a lesser likelihood of damaging surrounding tissues, which ultimately leads to better patient outcomes and satisfaction. The incorporation of this technology is critical, particularly in cases where traditional methods might be less effective. Furthermore, Rotational Atherectomy Devices are notable for their ability to rapidly and evenly remove plaque, especially in heavily calcified arteries. This type underscores the ongoing innovation within the UK Atherectomy Devices Market, catering to the need for more nuanced and effective treatments as patient demographics and health conditions evolve. The market dynamics highlight a trend towards minimally invasive procedures, reflecting a broader change in patient care strategies across the UK healthcare landscape. Increasing occurrences of cardiovascular diseases necessitate these advanced device types, as they promise improved patient recoveries, reduced hospital stays, and overall cost-effectiveness in treatment. Emerging technologies and ongoing research in the field are anticipated to enhance the capabilities and applications of these devices, further embedding them into the standard practices of cardiovascular care. Challenges remain, such as market competition and regulatory hurdles, but the potential for market growth remains significant as healthcare professionals increasingly recognize the importance of these devices in optimizing patient outcomes within the UK. The ongoing development and enhancement of these various types demonstrate their essential role in meeting the challenges posed by cardiovascular diseases in the region, ensuring that the UK Atherectomy Devices Market remains integral to modern medical practices. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Atherectomy Devices Market Application Insights** The Application segment of the UK Atherectomy Devices Market is diverse, encompassing significant health concerns such as Coronary Artery Disease, Peripheral Artery Disease, and Carotid Artery Disease. Coronary Artery Disease represents a critical area of focus, contributing to a high rate of hospitalizations and interventions. Similarly, Peripheral Artery Disease is prevalent, impacting a large portion of the aging population in the UK, necessitating innovative solutions for effective treatment. Carotid Artery Disease is increasingly gaining attention due to its association with stroke risk, prompting ongoing advancements in atherectomy technology to enhance patient outcomes. As healthcare systems increasingly prioritize minimally invasive procedures, the demand for atherectomy devices tailored to these applications has surged. Investing in these specific areas not only addresses significant health challenges but also aligns with trends toward improved patient care pathways and enhanced recovery times. Overall, the applications associated with atherectomy devices are instrumental in addressing cardiovascular health issues, reflecting the growing need for effective and efficient therapeutic solutions in the UK healthcare landscape. **Atherectomy Devices Market****End-use****r Insights** The UK Atherectomy Devices Market is characterized by its diverse End-user landscape, where Hospitals, Cardiac Catheterization Labs, and Ambulatory Surgical Centers play pivotal roles. Hospitals are a primary focal point, as they handle a considerable volume of cardiovascular procedures, necessitating advanced atherectomy devices to ensure optimal patient outcomes. Cardiac Catheterization Labs have gained significance due to their specialized equipment and expert staff, offering a conducive environment for minimally invasive interventions, thus driving demand for high-quality atherectomy tools. Meanwhile, Ambulatory Surgical Centers are emerging as major players by providing accessible and cost-effective options for patients, allowing for faster recoveries and reduced hospital stays, which resonates with the increasing shift towards outpatient care in the UK. The integration of technology, such as advancements in imaging and device design, further enhances the attractiveness of these facilities, ensuring efficient and effective treatments. Moreover, the rising prevalence of cardiovascular diseases within the UK amplifies the need for reliable atherectomy solutions, positioning this market segment for notable growth. Overall, the UK Atherectomy Devices Market benefits from a robust infrastructure and an increasing focus on improving cardiovascular health outcomes across these key End-users. **Atherectomy Devices Market Material Insights** The UK Atherectomy Devices Market is increasingly influenced by the material segment, which includes options such as Stainless Steel, Polymers, and Composites. The predominant choice in many atherectomy devices has been Stainless Steel due to its robust mechanical properties and resistance to corrosion, making it suitable for long-term applications within the cardiovascular industry. Polymers are gaining traction for their lightweight characteristics and flexibility, enabling enhanced maneuverability during procedures. Composites combine the benefits of both materials, providing unique properties that improve device performance and patient outcomes. The demand for advanced materials aligns with the UK's commitment to enhancing healthcare technologies, contributing to significant growth. Additionally, ongoing research and development aimed at innovative material applications could present new opportunities to address evolving clinical needs and improve procedural effectiveness. As such, the material segment plays a pivotal role in driving the UK Atherectomy Devices Market forward. **UK Atherectomy Devices Market Key Players and Competitive Insights** The UK Atherectomy Devices Market is characterized by a dynamic and competitive landscape, driven by advancements in medical technology and a growing demand for minimally invasive procedures. The market is witnessing an increase in the adoption of atherectomy devices owing to the rising prevalence of cardiovascular diseases and the need for effective treatment options. Several key players are vying for market share, focusing on innovation, product differentiation, and strategic collaborations. The landscape is further influenced by the regulatory environment that governs the approval and use of medical devices within the UK, making it essential for companies to remain agile in their responses to evolving market dynamics and healthcare needs. Siemens Healthineers holds a significant presence in the UK Atherectomy Devices Market, leveraging its robust portfolio of imaging and diagnostic technologies to enhance the performance of its atherectomy solutions. The company's strengths lie in its innovative approach to developing devices that not only improve procedural outcomes but also enhance patient safety. Siemens Healthineers benefits from established relationships with healthcare providers and hospitals across the UK, allowing for widespread adoption of its products. Moreover, the company's commitment to research and development ensures that it remains at the forefront of technological advancements, enabling sustained growth and a competitive edge in the market. The focus on customer engagement and support also reinforces its reputation as a trusted partner in the healthcare industry. Spectranetics has carved out a notable position in the UK Atherectomy Devices Market, specializing in the development of energy-based devices for the treatment of peripheral vascular disease. The company's key products include laser atherectomy devices that are widely recognized for their effectiveness in treating complex blockages in blood vessels. Spectranetics' market presence is bolstered by its strong emphasis on clinical evidence supporting the efficacy of its devices, as well as partnerships and collaborations that enhance its distribution capabilities. The company’s strengths include a robust product pipeline and ongoing investment in innovative solutions, which are critical to meeting the needs of a growing patient population in the UK. Additionally, Spectranetics has engaged in strategic mergers and acquisitions that have expanded its market reach and enhanced its technological capabilities, positioning it as a leader in the atherectomy segment and contributing to its competitive strength in the UK. **Key Companies in the UK Atherectomy Devices Market Include** - Siemens Healthineers - Spectranetics - Abbott Laboratories - Boston Scientific - Covidien - Cardiovascular Systems - B. Braun - AngioDynamics - Johnson & Johnson - Medtronic - Philips - Avinger - Shubhendra - Terumo Corporation - CeloNova Biosciences **UK Atherectomy Devices****Market****Developments** In recent months, the UK Atherectomy Devices Market has witnessed several interesting developments. Companies like Siemens Healthineers and Abbott Laboratories have been actively investing in innovative technologies to enhance their product offerings. The advent of minimally invasive procedures has increased demand for atherectomy devices, significantly contributing to growth in market valuation. For example, in September 2023, Cardiovascular Systems announced the expansion of its technology suite through the acquisition of advanced imaging capabilities, positively impacting its competitive position. Notably, regulatory support from the UK's NHS has encouraged the adoption of these devices, aiming for improved patient outcomes in cardiovascular procedures. Recent market assessments indicate that the UK Atherectomy Devices Market is projected to grow, driven by advancements in technology and an aging population prone to cardiovascular diseases. In terms of major happenings, B. Braun and Covidien have also focused on collaborations aimed at enhancing product distribution across the UK, reflecting a strategic effort to expand their market reach. Overall, the UK market is seeing a robust integration of technological advancements, strategic mergers, and a focus on improving patient care. **UK Atherectomy Devices Market Segmentation Insights** **Atherectomy Devices Market Type Outlook** - Directional Atherectomy Devices - Orbital Atherectomy Devices - Laser Atherectomy Devices - Rotational Atherectomy Devices **Atherectomy Devices Market Application Outlook** - Coronary Artery Disease - Peripheral Artery Disease - Carotid Artery Disease **Atherectomy Devices Market End-user Outlook** - Hospitals - Cardiac Catheterization Labs - Ambulatory Surgical Centers **Atherectomy Devices Market Material Outlook** - Stainless Steel - Polymers - Composites ## Market Drivers ### Supportive Regulatory Environment The regulatory landscape in the UK is becoming increasingly supportive of the atherectomy devices market. Regulatory bodies are streamlining the approval processes for new medical devices, which facilitates quicker access to innovative atherectomy technologies. This supportive environment encourages manufacturers to invest in the development of new devices, knowing that they can bring their products to market more efficiently. Additionally, the UK government has been promoting initiatives aimed at improving cardiovascular health, which further bolsters the market. As a result, the atherectomy devices market is expected to benefit from this regulatory support, potentially leading to a 10% increase in market growth over the next few years. ### Advancements in Medical Technology Technological innovations play a crucial role in shaping the atherectomy devices market. The introduction of advanced devices, such as laser and rotational atherectomy systems, enhances the efficacy and safety of procedures. These innovations allow for more precise plaque removal, reducing the risk of complications and improving recovery times for patients. The UK healthcare system is increasingly adopting these advanced technologies, as they align with the growing emphasis on minimally invasive procedures. Market data indicates that the atherectomy devices market is projected to grow at a CAGR of around 8% over the next few years, driven by these technological advancements. As manufacturers continue to invest in research and development, the market is likely to see the emergence of even more sophisticated devices. ### Growing Investment in Healthcare Infrastructure Investment in healthcare infrastructure in the UK is another significant driver for the atherectomy devices market. The government and private sector are increasingly allocating funds to enhance medical facilities and upgrade existing equipment. This investment is crucial for the adoption of advanced medical technologies, including atherectomy devices. Enhanced healthcare infrastructure not only improves access to treatment but also ensures that healthcare providers are equipped with the latest technologies. Market data indicates that the UK healthcare expenditure is projected to rise by approximately 5% annually, which is likely to positively impact the atherectomy devices market. As facilities upgrade their capabilities, the demand for atherectomy devices is expected to increase correspondingly. ### Increasing Prevalence of Cardiovascular Diseases The increasing incidence of cardiovascular diseases in the UK is a primary driver for the atherectomy devices market. As the population ages, the prevalence of conditions such as atherosclerosis and coronary artery disease escalates. According to recent health statistics, cardiovascular diseases account for approximately 27% of all deaths in the UK, underscoring the urgent need for effective treatment options. Atherectomy devices, which facilitate the removal of plaque from arteries, are increasingly being adopted in clinical settings. This trend is likely to continue, as healthcare providers seek to improve patient outcomes and reduce the burden of cardiovascular diseases. The atherectomy devices market is expected to witness substantial growth, driven by the demand for innovative solutions that address these pressing health challenges. ### Rising Awareness of Minimally Invasive Treatments There is a growing awareness among both healthcare professionals and patients regarding the benefits of minimally invasive treatments. This trend is significantly impacting the atherectomy devices market, as these devices are designed to minimize patient trauma and enhance recovery. The UK population is increasingly seeking alternatives to traditional surgical methods, which often involve longer recovery times and higher risks. As a result, healthcare providers are more inclined to adopt atherectomy devices in their treatment protocols. Market analysis suggests that the demand for minimally invasive procedures is expected to rise, potentially leading to a 15% increase in the adoption of atherectomy devices over the next five years. This shift in patient preference is likely to drive market growth. ## Future Outlook The [Atherectomy Devices Market](https://www.marketresearchfuture.com/reports/atherectomy-devices-market-7322) is projected to grow at a 4.5% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditure. **New opportunities:** - Development of minimally invasive atherectomy systems for outpatient procedures. - Expansion of telehealth services for remote patient monitoring and follow-up. - Partnerships with hospitals for integrated atherectomy device training programs. By 2035, the atherectomy devices market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Type: Directional Atherectomy Devices (Largest) vs. Laser Atherectomy Devices (Fastest-Growing) In the UK atherectomy devices market, Directional Atherectomy Devices hold the largest market share due to their established technology and wide acceptance among healthcare professionals. The growth of this segment is primarily fueled by the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive procedures. Meanwhile, Laser Atherectomy Devices are gaining traction, contributing to the overall growth of the market as they offer advanced capabilities for complex cases, appealing to a subset of providers looking for innovative solutions. The growth trends in this segment are driven by several factors, including technological advancements, increased investments in healthcare, and a growing emphasis on patient-centered care. The rising incidence of peripheral arterial diseases and coronary artery diseases is pushing the demand for effective treatment options, which bodes well for both Directional and Laser Atherectomy Devices. Furthermore, the increasing awareness about the benefits of atherectomy procedures is expected to further fuel market growth across all segments. Directional Atherectomy Devices (Dominant) vs. Laser Atherectomy Devices (Emerging) Directional Atherectomy Devices dominate the UK atherectomy devices market due to their reliability and specific procedural advantages, allowing for efficient plaque removal while preserving arterial structure. These devices are widely utilized in various cardiovascular interventions, particularly for cases requiring precision. On the other hand, Laser Atherectomy Devices are emerging as a significant alternative, especially in complex lesions where traditional methods may fall short. Their ability to target and ablate tissue with minimal damage to surrounding structures makes them attractive to physicians seeking advanced options. The growing preference for minimally invasive techniques is elevating the position of both segments in the market, highlighting a shift toward innovation and enhanced patient outcomes. ### By Application: Coronary Artery Disease (Largest) vs. Peripheral Artery Disease (Fastest-Growing) In the UK atherectomy devices market, the application segment distribution highlights a significant share held by coronary artery disease, showcasing its dominance in the overall treatment landscape. Peripheral artery disease, while not as prominent as coronary artery disease, is rapidly gaining traction, revealing a growing focus on this area of treatment as healthcare providers elevate their awareness and intervention efforts. Growth trends indicate that peripheral artery disease is emerging as the fastest-growing segment due to rising prevalence and advancements in atherectomy technologies. Drivers such as an aging population, increasing lifestyles-related health issues, and enhancements in procedural outcomes are propelling demand for innovative solutions in the treatment of peripheral artery disease while coronary artery disease remains the largest focus area for established treatments and technologies. Coronary Artery Disease (Dominant) vs. Peripheral Artery Disease (Emerging) Coronary artery disease continues to dominate the application segment by accounting for a significant portion of procedures performed, showcasing a mature market with established treatment protocols. This sector benefits from substantial clinical expertise and a comprehensive range of atherectomy devices tailored for effective treatments. Conversely, peripheral artery disease is emerging as a key player in this space owing to a rapid increase in diagnosis and treatment options. As awareness grows and the clinical community adopts advanced technologies like directional atherectomy, the market position of peripheral artery disease is expected to strengthen, presenting new opportunities for growth. This comparative dynamic highlights the shifting focus from traditional dominance to emerging treatment needs. ### By End User: Hospitals (Largest) vs. Cardiac Catheterization Labs (Fastest-Growing) In the UK atherectomy devices market, hospitals hold the largest share among end users, driven by the high volume of procedures and advanced healthcare facilities that cater to patients with cardiovascular diseases. Cardiac catheterization labs are also significant contributors, with a growing demand for minimally invasive procedures, leading to a competitive landscape. Ambulatory surgical centers, while essential, represent a smaller segment in comparison to hospitals and catheterization labs. The growth trends in this segment indicate a shift towards outpatient procedures, supported by technological advancements and an increasing focus on cost-effective treatments. Hospitals are investing in new technologies to enhance surgical outcomes, while cardiac catheterization labs are expanding their services to accommodate the rising number of interventional cardiology procedures. The trend towards early diagnosis and treatment is fostering competition and innovation across all end-user segments. Hospitals (Dominant) vs. Cardiac Catheterization Labs (Emerging) Hospitals are the dominant segment in the UK atherectomy devices market, characterized by their extensive resources and capabilities to perform a wide range of complex procedures. They are equipped with state-of-the-art technology and skilled personnel, which facilitate high-quality patient care. On the other hand, cardiac catheterization labs, considered an emerging segment, have gained traction due to the increasing preference for minimally invasive treatments. These labs focus on specific cardiovascular procedures and demonstrate significant growth potential as patient awareness and acceptance of such therapies rise. Together, these segments reflect a dynamic landscape in the atherectomy devices market, pushing innovations and enhancing treatment options for patients. ### By Material: Stainless Steel (Largest) vs. Polymers (Fastest-Growing) In the UK atherectomy devices market, the material segment is primarily dominated by stainless steel, which is recognized for its durability, strength, and resistance to corrosion. This material accounts for a significant share of the overall market, making it the largest among its counterparts. On the other hand, polymers are gaining traction due to their lightweight properties and versatility, which appeals to both manufacturers and healthcare professionals, allowing for innovative designs and devices in the market. Growth trends indicate that although stainless steel holds a dominant position, polymers are emerging as a favorite choice, particularly in minimally invasive procedures where flexibility and adaptability are crucial. The adoption of advanced manufacturing technologies and an increasing focus on patient-centered approaches are driving the rise of polymers in the atherectomy device landscape. Furthermore, the continuous research and development in composites also shows promise for future applications, marking a significant shift in material preferences in the market. Materials: Stainless Steel (Dominant) vs. Polymers (Emerging) Stainless steel is the dominant material in the UK atherectomy devices market, prized for its high tensile strength and biocompatibility, making it the preferred choice for many surgical instruments. This material's reliability is crucial for ensuring safety and efficacy in medical procedures. In contrast, polymers are emerging rapidly, finding their niche in various atherectomy applications due to their adaptability and potential for cost-effectiveness. They allow manufacturers to innovate with lightweight and ergonomic designs, aligning with the trend toward patient-centric devices. Both materials have distinct characteristics that cater to different needs in the medical field, positioning them uniquely within the competitive landscape of the market. ## Competitive Benchmarking The [atherectomy devices market](https://www.marketresearchfuture.com/reports/atherectomy-devices-market-7322) is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Boston Scientific (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, leveraging their extensive research and development capabilities to enhance product offerings. Boston Scientific (US) appears to focus on expanding its product portfolio through technological advancements, while Medtronic (US) emphasizes strategic acquisitions to bolster its market position. Abbott Laboratories (US) seems to prioritize partnerships with healthcare providers to improve patient outcomes, collectively fostering a dynamic competitive environment that encourages continuous improvement and adaptation. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. The market structure is moderately fragmented, with several players competing for market share, yet the influence of major companies remains substantial. This competitive structure allows for a diverse range of products and innovations, catering to varying patient needs and preferences. In October 2025, Boston Scientific (US) announced the launch of its latest atherectomy device, which integrates advanced imaging technology to enhance procedural accuracy. This strategic move is likely to position the company as a leader in the market, as it addresses the growing demand for precision in cardiovascular interventions. The introduction of such innovative technology may not only improve patient outcomes but also strengthen Boston Scientific's competitive edge. In September 2025, Medtronic (US) completed the acquisition of a smaller firm specializing in minimally invasive cardiovascular devices. This acquisition is indicative of Medtronic's strategy to expand its product offerings and enhance its technological capabilities. By integrating new technologies, Medtronic aims to provide comprehensive solutions that meet the evolving needs of healthcare providers and patients alike, thereby reinforcing its market presence. In August 2025, Abbott Laboratories (US) entered into a strategic partnership with a leading telehealth provider to enhance remote patient monitoring capabilities for its atherectomy devices. This collaboration is significant as it reflects the growing trend towards digital health solutions, allowing for better patient management and follow-up care. Such initiatives may not only improve patient engagement but also position Abbott as a forward-thinking player in the atherectomy devices market. As of November 2025, current trends in the atherectomy devices market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into device functionality. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, advanced technology, and reliable supply chains. This shift may ultimately lead to enhanced patient care and improved clinical outcomes. ## Recent News & Developments In recent months, the UK Atherectomy Devices Market has witnessed several interesting developments. Companies like Siemens Healthineers and Abbott Laboratories have been actively investing in innovative technologies to enhance their product offerings. The advent of minimally invasive procedures has increased demand for atherectomy devices, significantly contributing to growth in market valuation. For example, in September 2023, Cardiovascular Systems announced the expansion of its technology suite through the acquisition of advanced imaging capabilities, positively impacting its competitive position. Notably, regulatory support from the UK's NHS has encouraged the adoption of these devices, aiming for improved patient outcomes in cardiovascular procedures. Recent market assessments indicate that the UK Atherectomy Devices Market is projected to grow, driven by advancements in technology and an aging population prone to cardiovascular diseases. In terms of major happenings, B. Braun and Covidien have also focused on collaborations aimed at enhancing product distribution across the UK, reflecting a strategic effort to expand their market reach. Overall, the UK market is seeing a robust integration of technological advancements, strategic mergers, and a focus on improving patient care. ## Report Scope | MARKET SIZE 2024 | 65.48(USD Million) | | --- | --- | | MARKET SIZE 2025 | 68.43(USD Million) | | MARKET SIZE 2035 | 106.25(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.5% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Boston Scientific (US), Medtronic (US), Abbott Laboratories (US), Cardiovascular Systems (US), Spectranetics (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Philips (NL) | | Segments Covered | Type, Application, End User, Material | | Key Market Opportunities | Advancements in minimally invasive techniques enhance growth potential in the atherectomy devices market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the atherectomy devices market. | | Countries Covered | UK | ## Frequently Asked Questions **Q: What is the current valuation of the UK atherectomy devices market?** A: The market valuation was $65.48 Million in 2024. **Q: What is the projected market size for the UK atherectomy devices market by 2035?** A: The projected valuation for 2035 is $106.25 Million. **Q: What is the expected CAGR for the UK atherectomy devices market during the forecast period 2025 - 2035?** A: The expected CAGR is 4.5% during the forecast period. **Q: Which companies are the key players in the UK atherectomy devices market?** A: Key players include Boston Scientific, Medtronic, Abbott Laboratories, and others. **Q: What are the main types of atherectomy devices available in the market?** A: The main types include Directional, Orbital, Laser, and Rotational Atherectomy Devices. **Q: What was the market size for Directional Atherectomy Devices in 2024?** A: The market size for Directional Atherectomy Devices was $15.0 Million in 2024. **Q: How much is the market for Laser Atherectomy Devices projected to grow by 2035?** A: The market for Laser Atherectomy Devices is projected to reach $30.0 Million by 2035. **Q: What applications are driving the demand for atherectomy devices?** A: The primary applications include Coronary Artery Disease, Peripheral Artery Disease, and Carotid Artery Disease. **Q: What was the market valuation for hospitals as end users of atherectomy devices in 2024?** A: The market valuation for hospitals was $30.0 Million in 2024. **Q: Which materials are predominantly used in the manufacturing of atherectomy devices?** A: The predominant materials include Stainless Steel, Polymers, and Composites. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-atherectomy-devices-market-53813*